# Efficacy of Vedolizumab in Crohn's Disease Patients Naive to Biological Therapy

> **NCT04362735** · — · UNKNOWN · sponsor: **Pontifícia Universidade Católica do Paraná** · enrollment: 100 (estimated)

## Conditions studied

- Crohn Disease

## Interventions

- **DRUG:** Vedolizumab

## Key facts

- **NCT ID:** NCT04362735
- **Lead sponsor:** Pontifícia Universidade Católica do Paraná
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-08-01
- **Primary completion:** 2021-01-20
- **Final completion:** 2021-04-01
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2020-04-27

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04362735

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04362735, "Efficacy of Vedolizumab in Crohn's Disease Patients Naive to Biological Therapy". Retrieved via AI Analytics 2026-07-18 from https://api.ai-analytics.org/clinical/NCT04362735. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*